HUMAN LYMPHOKINE-ACTIVATED KILLER CELLS

Information

  • Research Project
  • 3615782
  • ApplicationId
    3615782
  • Core Project Number
    N01CM087236
  • Full Project Number
    N01CM087236-006
  • Serial Number
    87236
  • FOA Number
  • Sub Project Id
  • Project Start Date
    3/15/1988 - 36 years ago
  • Project End Date
    -
  • Program Officer Name
  • Budget Start Date
    9/26/1990 - 34 years ago
  • Budget End Date
    2/28/1991 - 33 years ago
  • Fiscal Year
    1990
  • Support Year
  • Suffix
  • Award Notice Date
    -

HUMAN LYMPHOKINE-ACTIVATED KILLER CELLS

This contract shall provide lymphokine-activated killer (LAK) cells for use by the Surgery Branch, NCI in on-going clinical trials. Production of human LAK cells are to be performed for 3 patients per week. These cells will be derived from the patients' peripheral blood by multiple leukopheresis and will be supplied by the Surgery. Each patient that is leukopheresed will yield approximately 3-7 X 1010 cells daily. The number of patients and any modifications of cell activation will be at the discretion of the Project Officer.

IC Name
DIVISION OF CANCER TREATMENT
  • Activity
    N01
  • Administering IC
    CM
  • Application Type
    3
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
  • Ed Inst. Type
  • Funding ICs
  • Funding Mechanism
  • Study Section
  • Study Section Name
  • Organization Name
    ADVANCED BIOSCIENCE LABORATORIES, INC.
  • Organization Department
  • Organization DUNS
  • Organization City
    KENSINGTON
  • Organization State
    MD
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    20895
  • Organization District
    UNITED STATES